[ad_1]
The British variant of the coronavirus has sparked panic across Europe, with ties to the UK halted and fears that the vaccine, only approved byMother and that will be distributed in Europe from December 27. To be Pfizer to be Modern They then began testing to see if their products are effective against the variant as well.
Meanwhile, while some countries like Germany and Spain have extended the travel ban until January, the France announced the reopening of air, sea and rail links as of December 23, although with trials and limitations, hoping that the route Calais-Dover decongests.
The UK has seen a new spike in cases in the last 24 hours, reaching high levels 36,807, while deaths rose to 691, the highest daily number in several days. Finally, the total number of swabs performed remains at a European record level, equal to more than 420 thousand per day.
Testing of the English variant, Pfizer and Moderna on vaccines has begun
Pfizer me Modern confirmed that testing of the vaccine in positive patients for English variant coronavirus. The two companies say they are optimistic about the outcome, based on the data in their possession, they reported that they hope immunity will protect against the variant.
Even the CEO of Biontech, the German company that developed the vaccine with Pfizer, said it was “confident” that the efficacy remains high. Ugur SahinIn fact, he recalled that the proteins of the virus coincide 99% with those of the most widespread strains, so there is confidence that the vaccine will work.
“The vaccine also protects against infection”: the good news from AIFA
Giorgio Palù, president of the Italian pharmaceutical agency, explained that the vaccine will also be distributed in Italy from December 27 it would appear to induce sterilizing immunity. In essence, in addition to protecting against Covid disease, it would prevent an asymptomatic infection and make the subject non-contagious.
L ‘sterilizing immunityIn fact, it means that a vaccinated person not only does not develop severe symptoms of the disease (the first objective of the studies carried out to date), but does not become infected and therefore does not become capable of infecting.
[ad_2]
